Package Leaflet: Information for the User
Adolquir 25 mg Granules for Oral Solution EFG
Dexketoprofen
Contents of the Package Leaflet
Contents of the pack and additional information
This medicine is a pain reliever belonging to the group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
It is used in adults for the short-term symptomatic treatment of acute pain of mild to moderate intensity, such as muscle or joint pain, menstrual pain, and toothache.
Do not take Adolquir
Warnings and precautions
Consult your doctor or pharmacist before starting to take Adolquir:
Adolquir may hide the signs of an infection, such as fever and pain. Consequently, this medicine may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Avoid using this medicine if you have chickenpox.
Children and adolescents
This medicine has not been studied in children or adolescents. Therefore, safety and efficacy have not been established, and it should not be used in children or adolescents.
Other medicines and Adolquir
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription. There are some medicines that should not be taken together, and others may need a dose change if taken together.
Always inform your doctor, dentist, or pharmacist if, in addition to this medicine, you are using or are being administered any of the following medicines:
Not recommended combinations:
Combinations that require caution:
Combinations to be taken into account:
If you have any doubts about taking other medicines with Adolquir, consult your doctor or pharmacist.
Taking Adolquir with food, drinks, and alcohol
Generally, it is recommended to take the medicine with meals to reduce the possibility of stomach disorders (see also section 3, "Method of administration").
The use of NSAIDs in combination with alcohol may worsen the adverse reactions caused by the active substance.
Pregnancy, breastfeeding, and fertility
Do not take this medicine during the last three months of pregnancy or during breastfeeding. It may cause kidney and heart problems in your fetus. It may affect your and your baby's ability to bleed and delay or prolong labor more than expected.
Do not take Adolquir during the first six months of pregnancy unless it is clearly necessary and as directed by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time.
From the 20th week of pregnancy, Adolquir may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
The use of this medicine may impair fertility, so it is not recommended for use while trying to conceive or while investigating a fertility problem.
Driving and using machines
This medicine may slightly affect your ability to drive and use machines, as it may cause drowsiness, dizziness, and blurred vision as side effects. If you notice these effects, do not use machines or drive until these symptoms disappear. Ask your doctor for advice.
Adolquir contains sucrose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine. It contains 2.418 g of sucrose per dose, which should be taken into account in patients with diabetes mellitus.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The necessary dose of the medicine may vary, depending on the type, intensity, and duration of the pain. Your doctor will indicate how many sachets you should take per day and for how long.
The lowest effective dose should be used for the shortest necessary duration to alleviate the symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).
Adults over 18 years
Generally, the recommended dose is 1 sachet (25 mg of dexketoprofen) every 8 hours, not exceeding 3 sachets per day (75 mg).
Elderly patients or patients with renal or hepatic impairment
If you are an elderly patient or have mild renal impairment or mild to moderate hepatic impairment, it is recommended to start therapy with a maximum of 2 sachets per day (50 mg of dexketoprofen).
In elderly patients, this initial dose may be increased later according to the general recommended dose (75 mg of dexketoprofen) if the medicine has been well tolerated.
Do not use dexketoprofen if you have moderate or severe renal impairment or severe hepatic impairment. Consult your doctor or pharmacist if you are unsure.
Use in children and adolescents
This medicine should not be used in children and adolescents (under 18 years).
Method of administration
Dissolve the entire contents of a sachet in a glass of water; stir to help dissolve. The resulting solution should be taken immediately after reconstitution.
The medicine can be taken with or without food. Taking the medicine with food helps to reduce the risk of stomach disorders; however, if your pain is more intense and you need faster relief, take the sachet on an empty stomach (at least 15 minutes before any meal or food intake) because it will be absorbed more easily (see section 2, "Taking Adolquir with food, drinks, and alcohol").
If you take more Adolquir than you should
Consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91.562.04.20, indicating the medicine and the amount taken. It is recommended to bring the packaging and package leaflet of the medicine to the healthcare professional.
If you forget to take Adolquir
Do not take a double dose to make up for forgotten doses. Take the next dose when it is due (according to section 3, "How to take Adolquir").
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Possible adverse effects are detailed below according to their frequency. Since the list is based in part on adverse effects observed with the oral use of tablets, and the granule for oral solution is absorbed faster than tablets, it is possible that the actual frequency of adverse effects (gastrointestinal) may be higher in the granule for oral solution.
Frequent Adverse Effects: may affect up to 1 in 10 people
Nausea and/or vomiting, mainly pain in the upper abdominal quadrant, diarrhea, digestive disorders (dyspepsia).
Uncommon Adverse Effects: may affect up to 1 in 100 people
Rotatory sensation (vertigo), dizziness, somnolence, sleep disorders, nervousness, headache, palpitations, hot flashes, inflammation of the stomach wall (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, febrile sensation, and chills, general malaise.
Rare Adverse Effects: may affect up to 1 in 1,000 people
Peptic ulcer, perforation of peptic ulcer or bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention, and peripheral edema (e.g., swelling of ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute kidney failure.
Very Rare: may affect up to 1 in 10,000 people
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), ulcers on the skin, mouth, eyes, and genital areas (Stevens-Johnson syndrome and Lyell syndrome), swelling of the face or swelling of the lips and throat (angioedema), difficulty breathing due to narrowing of the airways (bronchospasm), shortness of breath, tachycardia, low blood pressure, pancreatitis, blurred vision, ringing in the ears (tinnitus), sensitive skin, sensitivity to light, itching, kidney problems. Decrease in the number of white blood cells (neutropenia), decrease in the number of platelets (thrombocytopenia).
Inform your doctor immediately if you notice any adverse effect of a gastrointestinal type at the start of treatment (e.g., stomach pain or burning or bleeding), if you have previously suffered from any of these adverse effects due to prolonged treatment with non-steroidal anti-inflammatory drugs, and especially if you are elderly.
Stop taking this medicine immediately if you notice the appearance of a skin rash or any lesion inside the mouth or on the genitals, or any other sign of allergy.
During treatment with non-steroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like Adolquir may be associated with a small increased risk of suffering a heart attack ("myocardial infarction") or a stroke ("stroke").
In patients with immune system disorders that affect connective tissue (systemic lupus erythematosus or mixed connective tissue disease), non-steroidal anti-inflammatory drugs can rarely cause fever, headache, and neck stiffness.
The most commonly observed adverse effects are of a gastrointestinal type. Peptic ulcers, perforation, or gastrointestinal bleeding, sometimes fatal, especially in elderly patients, may occur.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis, and Crohn's disease have been reported. Less frequently, inflammation of the stomach wall (gastritis) has been observed.
As with other NSAIDs, hematological reactions (purpura, aplastic and hemolytic anemia, and more rarely agranulocytosis and bone marrow hypoplasia) may appear.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on the envelope after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Adolquir
Appearance of Adolquir and Package Contents
Lemon-yellow granule.
The granule for oral solution is presented in single-dose heat-sealed envelopes of starch-aluminum-polyethylene.
It is presented in packages of 20 and 500 envelopes.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
LABORATORIOS MENARINI, S.A.
Alfons XII, 587
08918 Badalona (Barcelona) Spain
Date of the Last Revision of this Prospectus:April 2023
Other Sources of Information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/.
The average price of ADOLQUIR 25 MG ORAL SOLUTION GRANULES in October, 2025 is around 4 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.